Looking back to 95 days ago, ARIAD Pharmaceuticals, Inc. (NASD: ARIA) priced a 15,307,000 share secondary stock offering at $19.60 per share. Buyers in that offering made a considerable investment ...
Looking back to 4 days ago, ARIAD Pharmaceuticals, Inc. (NASD: ARIA) priced a 15,307,000 share secondary stock offering at $19.60 per share. Buyers in that offering made a considerable investment into ...
Staged at the Hordern Pavilion on Thursday night, the first ARIA Awards to be held since the Covid-19 pandemic brought some glitz and glamour back to NSW with a stunning red carpet. But it was once ...
Two Boston-based PR firms have launched a collaboration to enable them to offer broader services to healthcare technology companies. Aria Marketing and Escalate PR will be better able to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback